Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3002

1.

Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology.

Woods JJ, Skelding KA, Martin KL, Aryal R, Sontag E, Johnstone DM, Horvat JC, Hansbro PM, Milward EA.

Brain Behav Immun. 2019 Oct 15. pii: S0889-1591(19)30454-4. doi: 10.1016/j.bbi.2019.10.014. [Epub ahead of print] Review.

PMID:
31626972
2.

Finding Diagnostically Useful Patterns in Quantitative Phenotypic Data.

Aitken S, Firth HV, McRae J, Halachev M, Kini U, Parker MJ, Lees MM, Lachlan K, Sarkar A, Joss S, Splitt M, McKee S, Németh AH, Scott RH, Wright CF, Marsh JA, Hurles ME, FitzPatrick DR; DDD Study.

Am J Hum Genet. 2019 Oct 2. pii: S0002-9297(19)30355-6. doi: 10.1016/j.ajhg.2019.09.015. [Epub ahead of print]

3.

The Advocacy Journal Club.

Talmon G, Wolf A, Molani M, Martin K, Waibel E, Jacobs J, Wisecarver J.

Am J Clin Pathol. 2019 Oct 11. pii: aqz154. doi: 10.1093/ajcp/aqz154. [Epub ahead of print]

PMID:
31602461
4.

Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways.

Horgusluoglu-Moloch E, Risacher SL, Crane PK, Hibar D, Thompson PM, Saykin AJ, Nho K; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Sci Rep. 2019 Oct 10;9(1):14498. doi: 10.1038/s41598-019-50507-3.

5.

Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice.

Martin KA, Hum NR, Sebastian A, He W, Siddiqui S, Ghosh PM, Pan CX, de Vere White R, Loots GG.

Int J Mol Sci. 2019 Oct 9;20(20). pii: E4983. doi: 10.3390/ijms20204983.

6.

Photobiomodulation Mitigates Cerebrovascular Leakage Induced by the Parkinsonian Neurotoxin MPTP.

Miguel MS, Martin KL, Stone J, Johnstone DM.

Biomolecules. 2019 Oct 4;9(10). pii: E564. doi: 10.3390/biom9100564.

7.

Escitalopram for agitation in Alzheimer's disease (S-CitAD): Methods and design of an investigator-initiated, randomized, controlled, multicenter clinical trial.

Ehrhardt S, Porsteinsson AP, Munro CA, Rosenberg PB, Pollock BG, Devanand DP, Mintzer J, Rajji TK, Ismail Z, Schneider LS, Baksh SN, Drye LT, Avramopoulos D, Shade DM, Lyketsos CG; S-CitAD Research Group.

Alzheimers Dement. 2019 Oct 3. pii: S1552-5260(19)35112-X. doi: 10.1016/j.jalz.2019.06.4946. [Epub ahead of print]

PMID:
31587995
8.

Comparison of Associations with Different Macular Inner Retinal Thickness Parameters in a Large Cohort: The UK Biobank.

Khawaja AP, Chua S, Hysi PG, Georgoulas S, Currant H, Fitzgerald TW, Birney E, Ko F, Yang Q, Reisman C, Garway-Heath DF, Hammond CJ, Khaw PT, Foster PJ, Patel PJ, Strouthidis N; UK Biobank Eye and Vision Consortium.

Ophthalmology. 2019 Aug 21. pii: S0161-6420(19)31937-2. doi: 10.1016/j.ophtha.2019.08.015. [Epub ahead of print]

PMID:
31585827
9.

A Novel Panel of 80 RNA Biomarkers with Differential Expression in Multiple Human Solid Tumors against Healthy Blood Samples.

Delmonico L, Obenauer JC, Qureshi F, Alves G, Costa MASM, Martin KJ, Fournier MV.

Int J Mol Sci. 2019 Oct 2;20(19). pii: E4894. doi: 10.3390/ijms20194894.

10.

Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy.

Faist B, Schlott F, Stemberger C, Dennehy KM, Krackhardt A, Verbeek M, Grigoleit GU, Schiemann M, Hoffmann D, Dick A, Martin K, Hildebrandt M, Busch DH, Neuenhahn M.

PLoS One. 2019 Sep 30;14(9):e0223258. doi: 10.1371/journal.pone.0223258. eCollection 2019.

11.

Injustice Appraisal but not Pain Catastrophizing Mediates the Relationship Between Perceived Ethnic Discrimination and Depression and Disability in Low Back Pain.

Ziadni MS, Sturgeon JA, Bissell D, Guck A, Martin KJ, Scott W, Trost Z.

J Pain. 2019 Sep 25. pii: S1526-5900(19)30815-6. doi: 10.1016/j.jpain.2019.09.007. [Epub ahead of print]

PMID:
31562992
12.

Multimodal Hippocampal Subfield Grading For Alzheimer's Disease Classification.

Hett K, Ta VT, Catheline G, Tourdias T, Manjón JV, Coupé P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Sep 25;9(1):13845. doi: 10.1038/s41598-019-49970-9.

13.

GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses.

Kashyap AS, Fernandez-Rodriguez L, Zhao Y, Monaco G, Trefny MP, Yoshida N, Martin K, Sharma A, Olieric N, Shah P, Stanczak M, Kirchhammer N, Park SM, Wieckowski S, Laubli H, Zagani R, Kasenda B, Steinmetz MO, Reinecker HC, Zippelius A.

Cell Rep. 2019 Sep 24;28(13):3367-3380.e8. doi: 10.1016/j.celrep.2019.08.057.

14.

New Perspective for Non-invasive Brain Stimulation Site Selection in Mild Cognitive Impairment: Based on Meta- and Functional Connectivity Analyses.

Liu J, Zhang B, Wilson G, Kong J; Alzheimer’s Disease Neuroimaging Initiative.

Front Aging Neurosci. 2019 Aug 27;11:228. doi: 10.3389/fnagi.2019.00228. eCollection 2019.

15.

Are Individuals Who Engage in More Frequent Self-Regulation Less Susceptible to Mental Fatigue?

Martin K, Thompson KG, Keegan R, Rattray B.

J Sport Exerc Psychol. 2019 Sep 11:1-9. doi: 10.1123/jsep.2018-0222. [Epub ahead of print]

PMID:
31509795
16.

Developmental Outcomes of Extremely Preterm Infants with a Need for Child Protective Services Supervision.

McGowan EC, Laptook AR, Lowe J, Peralta-Carcelen M, Chowdhury D, Higgins RD, Hintz SR, Vohr BR; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

J Pediatr. 2019 Sep 6. pii: S0022-3476(19)30971-0. doi: 10.1016/j.jpeds.2019.07.063. [Epub ahead of print]

PMID:
31500860
17.

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial.

Hausenloy DJ, Kharbanda RK, Møller UK, Ramlall M, Aarøe J, Butler R, Bulluck H, Clayton T, Dana A, Dodd M, Engstrom T, Evans R, Lassen JF, Christensen EF, Garcia-Ruiz JM, Gorog DA, Hjort J, Houghton RF, Ibanez B, Knight R, Lippert FK, Lønborg JT, Maeng M, Milasinovic D, More R, Nicholas JM, Jensen LO, Perkins A, Radovanovic N, Rakhit RD, Ravkilde J, Ryding AD, Schmidt MR, Riddervold IS, Sørensen HT, Stankovic G, Varma M, Webb I, Terkelsen CJ, Greenwood JP, Yellon DM, Bøtker HE; CONDI-2/ERIC-PPCI Investigators.

Lancet. 2019 Sep 6. pii: S0140-6736(19)32039-2. doi: 10.1016/S0140-6736(19)32039-2. [Epub ahead of print]

18.

Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial.

Ang GS, Fenwick EK, Constantinou M, Gan ATL, Man REK, Casson RJ, Finkelstein EA, Goldberg I, Healey PR, Pesudovs K, Sanmugasundram S, Xie J, McIntosh R, Jackson J, Wells AP, White A, Martin K, Walland MJ, Crowston JG, Lamoureux EL.

Br J Ophthalmol. 2019 Sep 5. pii: bjophthalmol-2018-313396. doi: 10.1136/bjophthalmol-2018-313396. [Epub ahead of print]

PMID:
31488427
19.

Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.

Bellorin-Font E, Vasquez-Rios G, Martin KJ.

Curr Osteoporos Rep. 2019 Sep 4. doi: 10.1007/s11914-019-00533-x. [Epub ahead of print] Review.

PMID:
31485996
20.

Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential.

Whitehead M, Osborne A, Widdowson PS, Yu-Wai-Man P, Martin KR.

J Diabetes Res. 2019 Aug 14;2019:5140521. doi: 10.1155/2019/5140521. eCollection 2019. Review.

Supplemental Content

Loading ...
Support Center